M 613 (Levetiracetam 250 mg)

Pill imprint M 613 has been identified as Levetiracetam 250 mg.

Levetiracetam is used in the treatment of seizures; epilepsy; bipolar disorder; new daily persistent headache; neuralgia (and more), and belongs to the drug class pyrrolidine anticonvulsants. Risk cannot be ruled out during pregnancy. Levetiracetam 250 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for M 613

Levetiracetam 250 mg M 613
Levetiracetam
Imprint:
M 613
Strength:
250 mg
Color:
White
Size:
10.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Pyrrolidine anticonvulsants
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
00378-5613
Inactive Ingredients:
silicon dioxide
croscarmellose sodium
hypromelloses
magnesium stearate
microcrystalline cellulose
polydextrose
polyethylene glycol
povidone
sodium lauryl sulfate
titanium dioxide
triacetin
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
51079-0820 UDL Laboratories Inc
35356-0429 Lake Erie Medical and Surgical Supply (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web2)